Sangui Biotech International (HAM:SBH) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Sangui Biotech International Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Sangui Biotech International's net issuance of preferred for the three months ended in Mar. 2023 was €0.00 Mil. The number is 0, which means that Sangui Biotech International has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Sangui Biotech International's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2023 was €0.00 Mil.

Sangui Biotech International Net Issuance of Preferred Stock Historical Data

The historical data trend for Sangui Biotech International's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Net Issuance of Preferred Stock Chart

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Net Issuance of Preferred Stock

Get a 7-Day Free Trial

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Net Issuance of Preferred Stock	Get a 7-Day Free Trial															-	-	-	-	-

Sangui Biotech International Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Sangui Biotech International Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (HAM:SBH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (HAM:SBH) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

SGBI:USA

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.